Mrs Claire Stewart, MS, CCC-SLP | |
3057 Lorna Rd Ste 220, Birmingham, AL 35216-4518 | |
(205) 987-8080 | |
(205) 987-8080 |
Full Name | Mrs Claire Stewart |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 3057 Lorna Rd Ste 220, Birmingham, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194814764 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 2157 (Alabama) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Claire Stewart, MS, CCC-SLP 3325 Lorna Rd # 2234, Birmingham, AL 35216-7404 Ph: (205) 987-8080 | Mrs Claire Stewart, MS, CCC-SLP 3057 Lorna Rd Ste 220, Birmingham, AL 35216-4518 Ph: (205) 987-8080 |
News Archive
Life-threatening fungal infections affect more than two million people worldwide. Effective antifungal medications are very limited.
Neurologists at Stanford have developed a diagnostic tool that can translate the brain's activity into sounds for the detection of silent seizures.
Studies of a more-rapid-acting injectable human insulin formulation (VIAject®) in the treatment of type 1 and type 2 diabetes and of a novel insulin analog formulation (Vialog™) in an animal model of diabetes were reported this week in three poster presentations at the 70th Scientific Sessions of the American Diabetes Association in Orlando, Florida. The findings are based upon results from recent clinical and preclinical studies sponsored by Biodel Inc..
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 5mg/ 5ml of Oxycodone HCl liquid which is used in treatment of moderate to severe acute and chronic pain. Wockhardt is launching the product soon and will be amongst the few generic versions of this product in the market.
Tanox, Inc. announced today that it has begun dosing patients in its Phase 2 clinical trial of TNX-355 for the treatment of the human immunodeficiency virus (HIV).
› Verified 4 days ago
Ms. Lynn Gazaway Roebuck, M. S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 120 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3939 | |
Katherine Seal, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 120 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3944 Fax: 205-413-4914 | |
Mrs. Gina Marino Salvagio, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1521 Woodridge Place, Birmingham, AL 35216 Phone: 205-567-2201 Fax: 205-823-6554 | |
Angie Smith Pruett, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2970 Lorna Rd, Birmingham, AL 35216 Phone: 205-981-8900 | |
Ms. Jacquelynn Adams-carr, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 530 Beacon Parkway West, Birmingham, AL 35209 Phone: 205-253-0098 Fax: 205-854-1953 | |
Rebekah Patterson Waldrum, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 101 Oslo Cir, Birmingham, AL 35211 Phone: 205-944-3921 Fax: 205-413-4914 | |
Lauranne Krepps, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 419 Broadway St, Birmingham, AL 35209 Phone: 407-756-9469 |